Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Landos Biopharma Inc | LABP | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
22,30 | 22,185 | 22,43 | 22,235 | 22,25 |
Aktuelle News
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
25.3.2024 | 13:31 | PRNUS | AbbVie to Acquire Landos Biopharma, Further Strengthening.. |
25.3.2024 | 13:30 | GLOBE | AbbVie to Acquire Landos Biopharma, Further Strengthening.. |
04.3.2024 | 22:14 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
04.3.2024 | 22:06 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
14.2.2024 | 22:01 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
04.1.2024 | 14:05 | EDGAR2 | Form 8-K - Current report |
21.11.2023 | 14:08 | EDGAR2 | Form 8-K - Current report |
09.11.2023 | 14:22 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
09.11.2023 | 14:08 | EDGAR2 | Form 8-K - Current report |
21.9.2023 | 14:00 | EDGAR2 | Form 8-K - Current report |
14.9.2023 | 14:11 | EDGAR2 | Form 8-K - Current report |
09.8.2023 | 14:18 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
09.8.2023 | 14:12 | EDGAR2 | Form 8-K - Current report |